PMF, one of the most complex and rare malignant tumors in MPNs, is frequently but not always accompanied by JAK2, CALR mutation, aberrant cytokine expression, bone marrow fibrosis and anemia, etc. [25–27]. This evidence concerns the gene JAK2 and anemia (phenotype).